Poultry E. coli Infection: Pathogenesis, Clinical Signs, and Control

Introduction

Avian colibacillosis, caused by avian pathogenic Escherichia coli (APEC), represents one of the most economically significant infectious diseases affecting poultry production worldwide [1, 16]. The disease manifests as a spectrum of localized and systemic conditions including respiratory tract infection, airsacculitis, pericarditis, perihepatitis, salpingitis, and fulminant septicemia [20, 27]. APEC strains are a subset of extraintestinal pathogenic E. coli (ExPEC) that possess specific virulence attributes enabling colonization of the avian respiratory epithelium and subsequent systemic dissemination [11, 17]. The clinical and economic burden of this pathogen is compounded by increasing antimicrobial resistance and the frequent involvement of E. coli as a secondary invader following viral or mycoplasmal infections [10, 34]. This article provides a comprehensive review of the pathogenesis, clinical presentation, diagnostic approaches, and control strategies for poultry E. coli infection, with emphasis on the underlying molecular mechanisms and epidemiological drivers.

Pathogenesis of Avian Pathogenic E. coli

Virulence Factors and Pathotype Classification

APEC strains harbour a repertoire of virulence genes that distinguish them from commensal E. coli isolates [8, 22]. These include genes encoding adhesins (e.g., type 1 fimbriae, P fimbriae, curli), iron acquisition systems (aerobactin, salmochelin, yersiniabactin), protectins (increased serum survival, Iss protein), and toxins (hemolysins, cytotoxic necrotizing factor 1) [11, 22, 31]. The presence of large virulence plasmids belonging to the ColV or ColBM plasmid families is a hallmark of APEC pathotypes [17]. Molecular characterization studies have identified multiple serogroups associated with avian colibacillosis, with O1, O2, O78, and O8 being among the most prevalent [20, 31, 35]. Phylogenetic analyses demonstrate that APEC isolates predominantly cluster within phylogroups A, B1, and C, whereas human ExPEC isolates more frequently belong to phylogroup B2 [8]. This phylogenetic distinction suggests host adaptation and differential virulence repertoire acquisition between avian and human pathogenic lineages [8, 30].

Adhesion and Invasion of Respiratory Epithelium

The respiratory tract constitutes the primary portal of entry for APEC in poultry [1, 11]. Inhalation of aerosolized E. coli from contaminated dust, litter, or fecal material allows the organism to reach the airways and air sacs [1, 21]. Using a chicken lung epithelial cell line (CLEC213) with pneumocyte type II-like characteristics, researchers have demonstrated that APEC can adhere to and subsequently invade respiratory epithelial cells [11]. Invasion is confirmed by confocal microscopy using green fluorescent protein (GFP)-labelled APEC, and infection of these cells results in significant upregulation of interleukin-8 (IL-8) gene expression, a chemoattractant for macrophages and heterophils [11]. This initial interaction between APEC and the respiratory epithelium triggers a cascade of innate immune responses that, if insufficient, permits bacterial translocation into the bloodstream and systemic dissemination [1, 11].

Systemic Dissemination and Host Immune Modulation

Following penetration of the respiratory mucosal barrier, APEC enters the bloodstream and colonizes internal organs including the liver, spleen, heart, and pericardium [1, 16]. The spleen, as a critical secondary lymphoid organ, undergoes marked pathological changes during systemic infection [2, 17]. Transcriptomic and proteogenomic analyses of chicken spleen following APEC infection reveal significant dysregulation of genes and proteins involved in phagosome maturation and lysosomal pathways [17]. Approximately 278 protein groups (5.7%) and 2,443 genes (24.4%) are dysregulated at 72 hours post-infection, with upregulated genes enriched in phagosome and lysosome pathways, indicating that the host activates phagosome maturation to eliminate invasive E. coli [17].

Stress conditions, such as those induced by elevated corticosterone levels, profoundly modulate the splenic response to APEC [2]. Experimental administration of corticosterone to broilers induces splenic atrophy through increased apoptosis and decreased cell proliferation, with a reduction in B cell numbers and a compensatory increase in heterophil accumulation [2]. In corticosterone-pretreated birds subsequently infected with APEC, the spleen exhibits enhanced heterophil antimicrobial peptide production and upregulation of phagolysosome pathways, with colony stimulating factor 3 receptor (CSF3R) and CCAAT/enhancer binding protein beta (CEBPB) identified as potential key regulators of heterophil maturation, chemotaxis, and effector function [2].

Biofilm Formation and Persistence

Biofilm formation represents a critical virulence attribute that facilitates bacterial persistence on poultry farms and within the host environment [3]. E. coli isolates from poultry demonstrate a high capacity for biofilm production, with 96.4% of poultry isolates exhibiting strong biofilm formation in microtiter plate assays [3]. A statistically significant pairwise correlation exists between multidrug resistance and biofilm formation, suggesting that these phenotypes may be co-selected under antimicrobial pressure [22]. Biofilm-producing strains are more likely to survive on farm surfaces, in water lines, and on litter, thereby perpetuating environmental contamination and flock reinfection cycles [3].

Clinical Signs and Pathological Manifestations

Respiratory and Systemic Colibacillosis

The clinical presentation of chicken E. coli infection varies according to the age of the bird, the route of exposure, the virulence of the infecting strain, and the presence of predisposing factors [20, 27]. In broilers, three primary forms are described: omphalitis (yolk sac infection) in neonates, colisepticemia in growing birds, and chronic colibacillosis with polyserositis in older birds [20]. Omphalitis is observed predominantly during the first week of life, with prevalence rates of 76.2% in week 1 and 23.8% in week 2 across affected flocks [20]. Colisepticemia manifests from the second week onward, with peak occurrence between weeks 4 and 6, presenting as acute depression, ruffled feathers, anorexia, and elevated mortality [20]. Chronic colibacillosis, characterized by fibrinous pericarditis, perihepatitis, and airsacculitis, is the most frequently observed form, accounting for 56.7% of E. coli deaths across all age groups [20].

Adapted from [20, 29, 34].

Gross and Histopathological Lesions

Necropsy findings in systemic colibacillosis include fibrinous polyserositis with involvement of the pericardium, liver capsule, and air sacs [1, 16]. Histopathological examination reveals fibrinoheterophilic exudate and necrotic debris within parabronchi, splenic fibrinoid necrosis, and bacterial colonies within liver sinusoids and cardiac muscle [1, 13]. Immunohistochemical staining using anti-E. coli antibodies confirms intralesional bacterial localization [1]. Experimental aerosol infection models in adult broiler breeders produce characteristic lesions including splenic fibrinoid necrosis, folliculitis, polyserositis, and impaction of parabronchi with fibrinoheterophilic exudate, replicating natural disease progression [1, 9].

Reproductive Tract Infection

In laying hens and breeder ducks, E. coli is a significant cause of salpingitis manifested as hemorrhagic follicular inflammation, exudative oviductal inflammation, and yolk peritonitis, leading to reduced egg production and increased culling [24, 29]. Experimental studies demonstrate that intravaginal inoculation of E. coli in combination with Enterococcus faecalis and Chlamydia psittaci induces typical salpingitis and yolk peritonitis, whereas single-pathogen inoculation produces milder or no oviductal inflammation [29]. The secondary E. coli infection via artificial insemination routes is an emerging concern in breeder flocks [29].

Co-infection Interactions

Synergy with Respiratory Viruses

Escherichia coli frequently acts as a secondary pathogen complicating viral respiratory infections in poultry [34, 35]. Co-infection models combining low pathogenic avian influenza virus (H9N2) with E. coli O78 demonstrate synergistic pathogenic effects, including increased clinical severity, higher mortality (60% survival in co-infected versus 84% in E. coli alone and 100% in virus alone), and more severe macroscopic and microscopic lesions compared to single infections [34]. The hemagglutination inhibition (HI) titre against LPAI virus is significantly elevated in co-infected birds, suggesting that E. coli may promote viral propagation through modulation of the immune response [34].

In infectious bronchitis virus (IBV) infection models, the combination of IBV genotype GVI-1 with E. coli serotype O8 produces significantly more severe gross lesions than either pathogen alone [35]. This co-infection model has been employed to evaluate vaccine efficacy, demonstrating that IBV vaccines offering partial protection against viral challenge may show reduced efficacy when E. coli co-infection is present [35].

Interaction with Mycoplasma

Co-infection with Mycoplasma gallisepticum and E. coli is a well-recognized clinical entity in poultry respiratory disease complexes [4]. Multi-omics analysis of this co-infection model reveals that key targets such as matrix metalloproteinase 2 (MMP2) and toll-like receptor 4 (TLR4) are significantly modulated, with downstream effects on dopamine and gamma-aminobutyric acid metabolic pathways [4]. This interaction highlights the need for multi-target therapeutic approaches when managing polymicrobial respiratory infections [4].

Immunosuppressive Virus Co-infections

Emerging evidence from metagenomic analysis of broilers with novel petechial hepatitis demonstrates complex co-infection scenarios involving antigenic variant infectious bursal disease virus (IBDV), multiple E. coli pathotypes (including APEC, intestinal pathogenic E. coli, and ExPEC), and other viral agents [13]. The immunosuppressive effects of IBDV predispose birds to secondary bacterial invasion, and the application of metagenomic sequencing proves valuable in identifying diverse potential pathogens when conventional diagnostic methods are limited [13].

Diagnostic Approaches

Conventional Bacteriological Methods

Diagnosis of poultry E. coli infection begins with clinical and necropsy observation combined with bacteriological culture [13, 20]. Samples from liver, spleen, pericardium, air sacs, or bone marrow are plated onto MacConkey agar and eosin-methylene blue agar, with characteristic pink (lactose-fermenting) colonies on MacConkey and metallic green sheen on EMB serving as presumptive identification [20, 26]. Confirmation is achieved through biochemical testing using the indole, methyl red, Voges-Proskauer, and citrate (IMVIC) panel [26]. Serotyping using O and H antigen antisera provides epidemiological information, with O78, O2, and O1 being among the most common serotypes identified in broiler colibacillosis cases [31].

Molecular Diagnostics

Polymerase chain reaction (PCR)-based methods enable rapid pathotype classification through detection of virulence-associated genes [3, 22]. Multiplex PCR panels targeting genes such as ecp (E. coli common pilus), uidA (beta-glucuronidase), stx1/stx2 (Shiga toxins), eae (intimin), bfp (bundle-forming pilus), aggR (transcriptional regulator of aggregative adherence fimbriae), elt/est (enterotoxins), and APEC-associated plasmid genes (iroN, iucD, iss) allow differentiation among enteropathogenic, enterohemorrhagic, enterotoxigenic, enteroaggregative, and avian pathogenic pathotypes [22]. Real-time PCR provides quantitative assessment of bacterial load in tissues and facilitates monitoring of treatment efficacy [22].

Whole-Genome Sequencing and Metagenomics

Whole-genome sequencing (WGS) using high-throughput sequencing platforms enables comprehensive characterization of antimicrobial resistance genes, virulence determinants, and phylogenetic relationships among APEC isolates [5, 10]. Analysis of 158 clinical E. coli strains from poultry in Shandong Province, China, using WGS identified 71 sequence types (STs), with ST10 (6.3%), ST155 (6.3%), and ST101 (5.7%) being most prevalent, and phylogroups B1 (39.9%), A (27.9%), and C (15.2%) dominating [10]. Metagenomic analysis of liver tissues from broilers with petechial hepatitis demonstrates the utility of shotgun sequencing in detecting unexpected pathogens and characterizing the full microbial community, including bacterial, viral, and fungal components, when conventional methods fail to identify the causative agent [13].

Antimicrobial Resistance

Resistance Patterns and Genetic Determinants

Antimicrobial resistance in poultry E. coli isolates has reached alarming levels globally, driven by the extensive use of antibiotics in poultry production [3, 6, 10, 26]. Phenotypic resistance profiles from multiple studies consistently demonstrate high rates of resistance to ampicillin (70-95%), tetracycline (29-86%), trimethoprim-sulfamethoxazole (64-85%), ciprofloxacin (10-71%), and enrofloxacin (57%) [3, 6, 10, 19, 26]. Multidrug resistance (MDR), defined as resistance to three or more antimicrobial classes, is observed in 31.8-46.2% of poultry isolates depending on geographic origin and sampling context [8, 10].

Compiled from [3, 6, 10, 19, 26].

Extended-Spectrum Beta-Lactamase (ESBL)-Producing E. coli

Poultry are recognized as a major reservoir of extended-spectrum beta-lactamase (ESBL)-producing E. coli (ESBL-EC), which represent a significant public health concern due to the potential for zoonotic transmission through the food chain [14, 15]. The CTX-M-type ESBL genes are the most frequently identified in poultry isolates and are a primary cause of ESBL-mediated resistance in both avian and human clinical contexts [14]. Broiler flocks can acquire ESBL-EC through positive day-old chicks or from contaminated pen environments, and mathematical modeling demonstrates that once introduced, the entire flock can become colonized within a single fattening period [15].

Co-occurrence of Resistance Genes and Mobile Genetic Elements

Whole-genome sequencing of poultry E. coli reveals co-occurrence of multiple resistance genes on mobile genetic elements, facilitating horizontal transfer [10]. Co-carriage of mcr (colistin resistance) genes with blaTEM, floR (florfenicol resistance), catA/B (chloramphenicol resistance), and oqx (quinolone resistance) genes is documented, and isolates co-harboring blaNDM-5/mcr-1.1 and mcr-3.24 have been identified in chickens [10]. The emergence of tet(X4) in poultry isolates signals a concerning trend in resistance to the last-resort antibiotic tigecycline [10].

Control Strategies

Biosecurity and Management Interventions

Effective control of poultry E. coli infection relies fundamentally on comprehensive biosecurity protocols and management practices that reduce environmental bacterial load and limit bird exposure [15, 21]. Mathematical modeling of ESBL-producing E. coli transmission demonstrates that increasing litter quantity and decreasing stocking density are effective interventions for reducing flock colonization rates [15]. When chicks are already positive at placement, litter quantity must be increased to at least six times the standard of 1000 g/m2 to achieve a measurable effect, whereas in contaminated pens, three times the standard litter quantity is sufficient [15]. Reduced stocking density of 20 kg/m2 significantly decreases infection incidence only in previously contaminated pens, and combinations of multiple measures (increased litter, reduced density, feed additives) produce additive benefits [15].

Airborne transmission of E. coli on poultry dust particles represents a significant route of barn-to-barn spread, particularly in areas with high farm density [21]. Ultraviolet (UV) light at 254 nm wavelength effectively inactivates airborne E. coli attached to dust particles, with inactivation rates exceeding 99.9% at contact times of 5.6 seconds under UV irradiance of 1707-3422 microW/cm2 [21]. The implementation of UV air scrubbers in ventilation systems may reduce the risk of aerosol transmission between poultry houses [21].

Vaccination

Vaccination against APEC remains a cornerstone of control programs, although variable efficacy has been reported [9, 24]. Autogenous vaccines, prepared from E. coli strains isolated from affected flocks on the farm, offer the advantage of antigenic matching to circulating field strains [9, 24]. In an aerosol model of colibacillosis in broiler breeders, vaccinated birds show significantly lower bacteriology scores (p < 0.01), reduced overall air sac lesion scores (p < 0.05), and lower total gross pathology scores compared to unvaccinated challenged controls (1.95 versus 2.8) [9]. Field application of autogenous vaccine in a laying hen flock experiencing septicemia, cellulitis, and skin wounds resulted in a rapid decrease in morbidity and mortality and improved egg production shortly after intramuscular administration [24].

Antimicrobial Therapy and Alternatives

Antimicrobial therapy using agents such as tetracyclines, sulfonamides, fluoroquinolones, and beta-lactams has historically been the primary intervention for colibacillosis outbreaks [25, 28, 32]. Pharmacokinetic studies of ampicillin and flumequine in E. coli-infected poultry have established dosing regimens that achieve therapeutic concentrations in target tissues [25, 28]. However, the emergence of MDR strains and regulatory pressure to reduce antibiotic use in food animals have driven the search for alternatives.

Several alternative strategies have demonstrated efficacy in experimental and field settings. Quorum sensing inhibitors (QSI-5) and growth inhibitors (GI-7) administered in drinking water reduce APEC-associated mortality by 90% and 80%, respectively, in orally challenged chickens, and reduce cecal APEC load by 2.2-2.3 logs and internal organ load by 1.2-1.4 logs compared to untreated controls [7]. The combination of QSI-5 and GI-7 reduced cumulative pathological lesion scores to zero, outperforming sulfadimethoxine treatment (score 0.53) [7].

Synthetic CpG oligodeoxynucleotides (CpG-ODNs) administered intramuscularly to neonatal broiler chicks provide protection against lethal E. coli septicemia equivalent to tetracycline or sodium sulfamethazine, while simultaneously enhancing immune cell recruitment rather than inducing the immunosuppressive effects observed with antibiotics [32]. Flow cytometry analysis reveals enrichment of immune cells in CpG-ODN-treated birds, whereas antibiotic-treated groups show marked decreases in macrophage and T-cell numbers [32].

Nanoparticle-Based Antimicrobials

Nanoparticle formulations offer a promising alternative to conventional antibiotics [12]. Chitosan-silver nanoparticles (Ch-Ag NPs) administered at 0.5 mg/kg body weight to broilers experimentally infected with E. coli demonstrate superior antibacterial effects compared to copper oxide nanoparticles (CuO-NPs) or silver nanoparticles (Ag-NPs) alone [12]. The Ch-Ag NP-treated group shows the highest weight gain, lowest bacterial counts, and lowest lesion scores in examined organs, with no detectable residues in edible tissues, suggesting potential as both an antimicrobial and growth-promoting agent in broiler production [12].

Herbal and Phytochemical Interventions

Botanical extracts have been investigated for their antimicrobial properties against APEC [4, 23]. Radix Isatidis Mixtures (RIM) demonstrate multi-pathway and multi-target activity in a co-infection model of Mycoplasma gallisepticum and E. coli, with significant modulation of MMP2 and TLR4 expression and reduction of dopamine and gamma-aminobutyric acid levels [4]. Molecular docking identifies Salvianolic acid A (binding affinity -10.1 kcal/mol) and compounds from licorice (-9.3 kcal/mol) as promising bioactive constituents [4]. However, not all herbal interventions yield consistent results; Peganum harmala seed extract shows limited in vivo antimicrobial activity against E. coli and long-term feeding is associated with hepatotoxicity characterized by increased relative liver weight and depletion of alkaline phosphatase, protein, albumin, and globulin [23].

flowchart TD
    A[Initial Flock Assessment], > B{Clinical Signs Present?}
    B, >|Yes| C[Necropsy & Bacteriological Culture]
    B, >|No| D[Biosecurity Audit & Risk Assessment]
    C, > E[Presumptive E. coli Identification]
    E, > F[Confirmation: PCR / Biochemical Testing]
    F, > G{Pathotype Determination}
    G, > H[APEC / ExPEC Pathotype]
    G, > I[Other Pathotype]
    H, > J[Antimicrobial Susceptibility Testing]
    I, > J
    J, > K[MDR / XDR Profile?]
    K, >|Yes| L[WGS for Resistance Gene Characterization]
    K, >|No| M[Select Targeted Antimicrobial]
    L, > N[Implement Enhanced Biosecurity]
    N, > O[Vaccination Strategy Decision]
    O, > P{Autogenous or Commercial Vaccine?}
    P, > Q[Autogenous Vaccine Preparation]
    P, > R[Commercial Vaccine Program]
    Q, > S[Monitor Flock Response & Reduce Antimicrobial Use]
    R, > S
    S, > T[Alternative Therapy Consideration]
    T, > U[Quorum Sensing Inhibitors / CpG-ODN / Nanoparticles]
    U, > V[Outcome Assessment: Mortality Reduction & Lesion Scores]
    V, > W[Adjust Program Based on Surveillance Data]
    W, > A

One Health Implications and Food Safety

Poultry E. coli infection carries implications beyond avian health, extending to food safety and human medicine [5, 8, 14, 30, 33]. APEC strains isolated from retail poultry meat share virulence gene profiles and phylogenetic characteristics with human ExPEC isolates responsible for urinary tract infections [8, 30, 33]. Sequence type ST131, a globally disseminated uropathogenic clone, has been identified in poultry meat isolates and clusters phylogenetically with human clinical ST131 strains [30]. Caenorhabditis elegans infection models demonstrate that poultry-source antimicrobial-resistant ExPEC significantly reduce nematode lifespan comparably to human urinary tract infection isolates, confirming their pathogenic potential [30].

The presence of nitrofurantoin-resistant and pre-resistant E. coli clones in poultry meat and chicken-based raw dog food raises further concerns about domestic hygiene and occupational exposure risk [5]. Whole-genome sequencing reveals that these clones span multiple phylogroups and have been identified across Europe, Canada, the United States, and Japan, with evidence of transmission to humans and causation of urinary tract infections [5]. The historical use of nitrofuran antibacterials (furazolidone, furaltadone, nitrofurazone) in poultry production during the 1970s and 1980s may have driven initial selection of these resistant clones [5].

Conclusions

Poultry E. coli infection remains a formidable challenge to the global poultry industry due to its multifactorial pathogenesis, diverse clinical presentations, and rapidly evolving antimicrobial resistance landscape. The capacity of APEC to colonize the respiratory epithelium, evade host immune responses, and disseminate systemically is mediated by a sophisticated arsenal of virulence factors encoded on chromosomal and plasmid-borne genetic elements [11, 17]. Stress-induced immunomodulation, particularly through corticosterone-mediated splenic atrophy and B cell depletion, exacerbates susceptibility and alters disease progression [2]. Co-infection with respiratory viruses and mycoplasma further amplifies disease severity and complicates diagnostic interpretation [4, 34, 35].

Effective control requires an integrated approach combining rigorous biosecurity, optimized management practices, autogenous or commercial vaccination, and judicious antimicrobial use informed by susceptibility testing [9, 15, 24]. The emergence of MDR, ESBL-producing, and colistin-resistant E. coli in poultry populations underscores the urgency of developing and deploying antibiotic-alternative strategies including quorum sensing inhibitors, CpG-ODNs, and nanoparticle formulations [7, 12, 32]. Continued surveillance at the poultry-human interface, supported by genomic epidemiology, is essential to monitor resistance transmission dynamics and inform evidence-based intervention policies [5, 10, 14].

References

[1] Kromann, S., Olsen, R., Bojesen, A. et al. Development of an aerogenous Escherichia coli infection model in adult broiler breeders. Scientific Reports.

[2] Chen, M., Wang, Z., He, Y. et al. Corticosterone reprograms splenic responses to avian pathogenic Escherichia coli infection in broiler chickens. Poultry Science.

[3] Sasoon, A., Nikkhahi, F., Javadi, A. et al. Biofilm Formation and Antibiotic Resistance Genes of Escherichia coli From Poultry Farms and Clinical Samples. Veterinary Medicine and Science.

[4] Jin, X., Huo, J., Yao, Y. et al. A multi-dimensional validation strategy of pharmacological effects of Radix Isatidis Mixtures against the co-infection of Mycoplasma gallisepticum and Escherichia coli in poultry. Poultry Science.

[5] Sealey, J., Astley, B., Mounsey, O. et al. Poultry-associated nitrofurantoin-resistant and pre-resistant Escherichia coli clones are found in multiple